Drugs which can influence the effect of oral anticoagulants
Lunde, I.; Lunde, P.K.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 1971 Suppl 18: 1-8
1971
ISSN/ISBN: 0029-2001 PMID: 5566978 Document Number: 43363
Document emailed within 1 workday
Related Documents
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893D'Angelo, A.; Crippa, L.; Agazzi, A.; Della Valle, P.; Anzalone, N.; Garlando, A.M.; D'Angelo, S.V. 1995: Oral anticoagulants: old drugs with a promising future Haematologica 80(2 Suppl): 92-101
Verstraete, M. 1978: The interaction between drugs and oral anticoagulants of the coumarin group La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(13-16): 505-508
Sawicka-Powierza, J.; Rogowska-Szadkowska, D.; Ołtarzewska, A.M.łg.; Chlabicz, S.ła. 2008: Factors influencing activity of oral anticoagulants. Interactions with drugs and food Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(143): 458-462
Papacostas, C.A.; Weiss, L.M.; Soloff, L.A. 1970: Influence of anticoagulants and autonomic drugs on plasma free fatty acids and glucose Archives Internationales de Pharmacodynamie et de Therapie 187(1): 46-51
Apostoae, F.; Tarţău, L.; Cimpoeşu, D.; Lupuşoru, C.ăt.ăl.E. 2011: Pharmacoepidemiologic investigations about the interactions between oral anticoagulants and other drugs in patients with hemostasis disorders Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(4): 1155-1161
Juska, D.; Tyszkiewicz, Z.; Gawlik, Z.; Lewandowska, T. 1979: Effect of immunosuppressors, anticoagulants and antiphlogistic drugs on experimental Masugi nephritis. II. Acenocoumarol Patologia Polska 30(4): 505-528
Camatte, R.; Gauthier, A.P.; Gerolami, A.; Sarles, H. 1970: Digestive hemorrhage due to drugs (except anticoagulants). 80 cases Marseille Medical 107(1): 9-19
2010: INR self-monitoring and oral anticoagulants Prescrire International 19(107): 130-132
Frost, T.; Loveday, D. 1980: Oral anticoagulants and antithrombin IIi Medical Journal of Australia 2(4): 220
Neuzil, K.M.; Morgan, H.J. 1991: Hemarthrosis and oral anticoagulants Journal of the Tennessee Medical Association 84(4): 180-181
Le Mao, R.ël.; Tromeur, C.éc.; Fofana, A.; Leroyer, C.; Lacut, K. 2018: Direct oral anticoagulants La Revue du Praticien 68(5): 475-482
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Erich, W.B.; van der Meer, F.J. 1996: Optimal treatment with oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 140(36): 1830-1831
Hitzeman, N.; Applebaum, S. 2008: Oral anticoagulants vs. antiplatelet therapy American Family Physician 77(9): 1250-1252
De Moerloose, P.; Casini, A.; Boehlen, F.; Fontana, P. 2013: New oral anticoagulants: from theory to practice Revue Medicale Suisse 9(369): 104-107
Jullian, M.; Youlton, R.; Rivera, L. 1983: Embryopathy induced by oral anticoagulants Revista Medica de Chile 111(10): 1045-1048
Prins, M.H.; ten Cate, J.W. 1996: Optimal treatment with oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 140(20): 1059-1061
Wehrlin, N. 1974: Oral anticoagulants: anti-vitamin K Revue de l'Infirmiere 24(5): 475-480
Lourenço, D.M.; Morelli, V.M.; Vignal, C.V. 1998: Treatment for overdose of oral anticoagulants Arquivos Brasileiros de Cardiologia 70(1): 9-13